Anavex Outlines Corporate Milestones, Drug Advancement Plans for 2008

Geneva, Switzerland — January 22, 2008 — Anavex Life Sciences Corp. (“ANAVEX”) (OTCBB: AVXL) reported today that the company achieved significant development of its lead drug candidates and in the growth of its management and scientific teams during 2007.  The company further disclosed key corporate objectives for 2008.“This past year has been extremely successful for…